Glytone Acne Spot Treatment (Genesis Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Glytone Acne Spot Treatment drug offered from Genesis Pharmaceutical, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genesis Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | sulfur, resorcinol |
SUBSTANCE NAME: | RESORCINOL; SULFUR |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | LOTION |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2016-10-21 |
END MARKETING DATE: | 0000-00-00 |
Glytone Acne Spot Treatment HUMAN OTC DRUG Details:
Item Description | Glytone Acne Spot Treatment from Genesis Pharmaceutical, Inc. |
LABELER NAME: | Genesis Pharmaceutical, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20; 80(mg/mL; mg/mL) |
START MARKETING DATE: | 2016-10-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 64760-708_22f19e97-e5e5-483e-915f-23c7dcbfe91c |
PRODUCT NDC: | 64760-708 |
APPLICATION NUMBER: | part333D |
Other RESORCINOL; SULFUR Pharmaceutical Manufacturers / Labelers: